Why Is Myopia Care a Postcode Lottery in the UK? What Every Parent Needs to Know in 2026
- Richard Kadri-Langford
- 15 hours ago
- 3 min read
Childhood myopia—short‑sightedness—is rising at a pace that’s worrying parents, teachers, and eye‑care professionals across the UK. Despite the growing number of children affected, the level of care they receive varies dramatically depending on where they live and whether their families can afford private treatment. A recent narrative review published in Cureus ("A Narrative Review of Childhood Myopia Management Across the NHS and Private Sector in the UK") highlights just how uneven childhood myopia management is across the NHS and private sector.
If you’re a parent wondering whether your child is getting the right support, or someone interested in public eye health, this article breaks down what the review found, why it matters, and what you can do next.
What the Review Looked At
The Cureus review examined how childhood myopia is being managed across both the NHS and the private eye‑care sector in the UK. It found a system-wide inconsistency in the availability, quality, and type of treatments offered to children with progressive myopia.
And the timing couldn’t be more critical—myopia prevalence is climbing rapidly, and without early intervention, children face higher lifetime risks of eye diseases such as glaucoma, retinal detachment, and myopic maculopathy.
The NHS: Excellent for Eye Health—But Limited for Modern Myopia Control
One of the most important findings of the narrative review is that most NHS services still provide single‑vision lenses as the default correction for children. These lenses help children see clearly but do not slow down myopia progression.
More advanced treatments—such as myopia‑control contact lenses, orthokeratology, specialised spectacle lenses, and low‑dose atropine—are either not widely available or not routinely offered within NHS services. This echoes wider research showing that UK eye‑care practitioners find the provision of modern myopia management “variable” and often limited by funding and systemic pressures within the NHS.
Why the NHS struggles with myopia control:
Treatments like orthokeratology or myopia‑control spectacles are not currently funded.
NHS clinics are designed for clinical need, not preventative treatments.
Many services face resource constraints, making it harder to implement new care pathways.
The result? Children relying solely on the NHS may miss the early interventions proven to reduce long‑term risk.
The Private Sector: Wider Options—but Not Accessible to All
In contrast, many private optometry practices now offer the full range of modern myopia‑control treatments, including:
Orthokeratology
Myopia‑control soft contact lenses
Peripheral‑plus myopia‑control spectacles
Low‑dose atropine (where available)
These treatments have been shown in evidence reviews to reduce myopia progression by 40–60% on average over 1–3 years (source: college-optometrists.org).
But here’s the problem: Cost is a major barrier. Focus‑group research shows that UK practitioners feel uncomfortable discussing the financial burden with parents, and that many families simply cannot afford these treatments despite wanting them for their children.
This creates a worrying situation where children with the greatest need may not have the means to access proven care.
A Postcode Lottery: What the Review Reveals About UK Care
The Cureus review’s most striking conclusion is the postcode‑dependent nature of childhood myopia management in the UK. Access varies not only between NHS and private care, but also among regions and individual practices.
Additional studies support this, showing that practitioners across the UK report:
Inconsistent service provision,
Uncertainty around clinical guidance, and
Concerns about future litigation if myopia control is not discussed with parents. (source: BMJ)
The growing body of UK consensus work recommends standardising guidance, improving training, and ensuring equitable access, potentially through public funding for children at risk of fast progression.
Final Thoughts: The UK Needs a Fairer, More Consistent Myopia‑Care System
The Cureus narrative review paints a clear picture: children in the UK do not have equal access to modern, effective myopia management. The NHS excels in many areas of paediatric eye care, but modern myopia‑control interventions still sit mostly in the private sector—largely due to funding limitations, resource pressures, and system‑level barriers.
With childhood myopia rising, the UK urgently needs:
Clearer national guidance,
Better practitioner training, and
Fair, accessible funding models for families.
Until then, awareness is your strongest tool. The more parents understand the risks of progressive myopia—and the options available—the better equipped they are to advocate for their child’s long‑term eye health.
If you’re concerned about your child’s vision and want to explore the latest treatment options, now is the perfect time to either start the conversation with your eye‑care professional and reading our Complete Guide to Myopia Control.
A Narrative Review of Childhood Myopia Management Across the NHS and Private Sector in the UK
Comments